Kendrick, K. M., Guastella, A. J., & Becker, B. in Behavioral Pharmacology of Neuropeptides: Oxytocin 321–348 (Springer, 2017).
Young, L. J. & Barrett, C. E. Can oxytocin treat autism? Science 347, 825–826 (2015).
Meyer-Lindenberg, A., Domes, G., Kirsch, P. & Heinrichs, M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 12, 524–538 (2011).
Leng, G. & Ludwig, M. Intranasal oxytocin: myths and delusions. Biol. Psychiatry 79, 243–250 (2016).
Beard, R., Singh, N., Grundschober, C. D., Gee, A. W. & Tate, E. High-yielding 18 F radiosynthesis of a novel oxytocin receptor tracer, a probe for nose-to-brain oxytocin uptake in vivo. Chem. Commun. 54, 8120–8123 (2018).
Lee, M. R. et al. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Mol. Psychiatry 23, 115–115 (2018).
Lee, M. R. et al. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nat. Commun. 11, 2783 (2020).
Modi, M. E., Connor-Stroud, F., Landgraf, R., Young, L. J. & Parr, L. A. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques. Psychoneuroendocrinology 45, 49–57 (2014).
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M. & Landgraf, R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 38, 1985–1993 (2013).
Smith, A. S., Korgan, A. C. & Young, W. S. Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice. Pharmacol. Res. 146, 104324 (2019).
Paloyelis, Y. et al. A spatiotemporal profile of in vivo cerebral blood flow changes following intranasal oxytocin in humans. Biol. Psychiatry 79, 693–705 (2016).
Martins, D. A. et al. Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans. Nat. Commun. 11, 1160 (2020).
Striepens, N. et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci. Rep. 3, 3440 (2013).
Quintana, D. S. et al. Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research. Mol. Psychiatry 26, 1–12, https://doi.org/10.1038/s41380-020-00864-7 (2020).
Yamamoto, Y. RAGE regulates oxytocin transport into the brain. Commun. Biol. 3, 1–4 (2020).
Yamamoto, Y. et al. Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice. Commun. Biol. 2, https://doi.org/10.1038/s42003-019-0325-6 (2019).
Carter, C. S. Oxytocin pathways and the evolution of human behavior. Annu. Rev. Psychol. 65, 17–39 (2014).
Ring, R. H. et al. Anxiolytic-like activity of oxytocin in male mice: Behavioral and autonomic evidence, therapeutic implications. Psychopharmacology 185, 218–225 (2006).
Sakamoto, T., Sugimoto, S. & Uekita, T. Effects of intraperitoneal and intracerebroventricular injections of oxytocin on social and emotional behaviors in pubertal male mice. Physiol. Behav. 212 (2019).
Mens, W. B. J., Witter, A. & Van Wimersma Greidanus, T. B. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF. Brain. Res. 262, 143–149 (1983).
Ermisch, A. et al. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Endocrinol. Exp. 19, 29–37 (1985).
Ferris, C. F. et al. Distinct BOLD Activation Profiles Following Central and Peripheral Oxytocin Administration in Awake Rats. Front. Behav. Neurosci. 9, https://doi.org/10.3389/fnbeh.2015.00245 (2015).
Dumais, K. M., Kulkarni, P. P., Ferris, C. F. & Veenema, A. H. Sex differences in neural activation following different routes of oxytocin administration in awake adult rats. Psychoneuroendocrinology 81, 52–62 (2017).
Galbusera, A. et al. Intranasal oxytocin and vasopressin modulate divergent brainwide functional substrates. Neuropsychopharmacology 42, 1420–1434 (2017).
Hollander, E. et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology 28, 193–198 (2003).
Hollander, E. et al. Oxytocin increases retention of social cognition in autism. Biol. Psychiatry 61, 498–503 (2007).
Quintana, D. S. et al. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: a peripheral effect-controlled within-subjects randomized dose-response fMRI trial. Psychoneuroendocrinology 69, 180–188 (2016).
Daughters, K. et al. Salivary oxytocin concentrations in males following intranasal administration of oxytocin: a double-blind, cross-over study. PLoS ONE 10, e0145104 (2015).
van IJzendoorn, M. H., Bhandari, R., van der Veen, R., Grewen, K. M. & Bakermans-Kranenburg, M. J. Elevated salivary levels of oxytocin persist more than 7 h after intranasal administration. Front. Neurosci. 6, 174 (2012).
Quintana, D. S. et al. Saliva oxytocin measuresDESP do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men. Horm. Behav. 102, 85–92 (2018).
Takeda, S., Kuwabara, Y. & Mizuno, M. Concentrations and origin of oxytocin in breast milk. Endocrinol. Jpn. 33, 821–826 (1986).
Petersson, M., Hulting, A. L., Andersson, R. & Uvnäs-Moberg, K. Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment. Neuroendocrinology 69, 202–208 (1999).
Maejima, Y. et al. Oral oxytocin delivery with proton pump inhibitor pretreatment decreases food intake. Peptides 128, 170312 (2020).
Groot, A. N. J. A. D. et al. Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers. J. Pharm. Pharmacol. 47, 571–575 (1995).
Kou, J. et al. A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin. Psychol. Med. 10, 1–10, https://doi.org/10.3389/fnbeh (2020).
Kirsch, P. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 25, 11489–11493 (2005).
Koch, S. B. J. et al. Intranasal oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology 41, 2041–2051 (2016).
Domes, G. et al. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 62, 1187–1190 (2007).
Spengler, F. B. et al. Kinetics and dose dependency of intranasal oxytocin effects on amygdala reactivity. Biol. Psychiatry 82, 885–894 (2017).
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L. & Petersen, S. E. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage 59, 2142–2154 (2012).
Watson, D., Clark, L. A. & Tellegen, A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 54, 1063–1070 (1988).
Friston, K. J. et al. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2, 189–210 (1994).
Flandin, G. & Friston, K. J. Analysis of family-wise error rates in statistical parametric mapping using random field theory. Hum. Brain Mapp. 40, 2052–2054 (2019).
Woo, C. W., Krishnan, A. & Wager, T. D. Cluster-extent based thresholding in fMRI analyses: Pitfalls and recommendations. NeuroImage 91, 412–419 (2014).
McCullough, M. E., Churchland, P. S. & Mendez, A. J. Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted? Neurosci. Biobehav. Rev. 37, 1485–1492 (2013).
Noguchi, K., Gel, Y. R., Brunner, E. & Konietschke, F. nparLD: an R software package for the nonparametric analysis of longitudinal data in factorial experiments. J. Stat. Softw. 50 (2012).
Cramer, A. O. J. et al. Hidden multiplicity in exploratory multiway ANOVA: prevalence and remedies. Psychon. Bull. Rev. 23, 640–647 (2016).
Cooper, H. & Hedges, L. V. The Handbook of Research Synthesis 1560–1562 (Russell Sage Foundation, 1994).
Coolican, H. Research Methods and Statistics in Psychology (Routledge, 2018).
Preacher, K. J. & Hayes, A. F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 40, 879–891 (2008).
Fan, L. et al. The human brainnetome atlas: a new brain atlas based on connectional architecture. Cereb. Cortex 26, 3508–3526 (2016).
Jurek, B. & Neumann, I. D. The oxytocin receptor: from intracellular signaling to behavior. Physiol. Rev. 98, 1805–1908 (2018).
Li, K., Nakajima, M., Ibañez-Tallon, I. & Heintz, N. A cortical circuit for sexually dimorphic oxytocin-dependent anxiety behaviors. Cell 167, 60–72 (2016).
Borland, J. M., Rilling, J. K., Frantz, K. J. & Albers, H. E. Sex-dependent regulation of social reward by oxytocin: an inverted U hypothesis. Neuropsychopharmacology 44, 97–110 (2019).
Gao, S. et al. Oxytocin, the peptide that bonds the sexes also divides them. PNAS 113, 7650–7654 (2016).
Lieberz, J. et al. Kinetics of oxytocin effects on amygdala and striatal reactivity vary between women and men. Neuropsychopharmacology 45, 1134–1140 (2019).
Luo, L. et al. Sex-dependent neural effect of oxytocin during subliminal processing of negative emotion faces. NeuroImage 162, 127–137 (2017).
